Director/PDMR Shareholding

RNS Number : 8781K

PureTech Health PLC

27 September 2016

 

PDMR DEALING NOTIFICATION

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Michael MacLean
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	PureTech Health plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Restricted share unit ("RSU"), each of which entitles the holder to one ordinary share of one pence each in the capital of PureTech Health plc ("Ordinary Share") GB00BY2Z0H74
b)	Nature of the transaction	Award of RSUs by PureTech Health plc to Michael MacLean pursuant to its Performance Share Plan. The RSUs were granted for nil consideration. The RSUs will vest in the following manner: 25% to vest on 30 June 2017, and remaining 75% shall vest in equal semi-annual instalments over the three years following 18 January 2017; provided that Michael MacLean continues to be employed by PureTech Health plc on each such vesting date. Following vesting, Michael MacLean will be required to make a payment of one pence per Ordinary Share on settlement of the RSUs.
c)	Price(s) and volume(s)	Price(s) Volume(s) Nil  150,000
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	26 September 2016
f)	Place of the transaction	Outside a trading venue

 

END

 

 

DSHFQLLLQKFXBBL